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Edited by Angel NebredaAbstract In order to investigate the importance of the PDK1–
PKB–GSK3 signalling network in regulating glycogen synthase
(GS) in the heart, we have employed tissue speciﬁc conditional
knockout mice lacking PDK1 in muscle (mPDK1/), as well
as knockin mice in which the protein kinase B (PKB) phosphor-
ylation site on glycogen synthase kinase-3a (GSK3a) (Ser21)
and GSK3b (Ser9) is changed to Ala. We demonstrate that in
hearts from mPDK1/ or double GSK3a/GSK3b knockin mice,
insulin failed to stimulate the activity of GS or induce its dephos-
phorylation at residues that are phosphorylated by GSK3. We
also establish that in the heart, both GSK3 isoforms participate
in the regulation of GS, with GSK3b playing a more prominent
role. This contrasts with skeletal muscle where GSK3b is the ma-
jor regulator of insulin-induced GS activity. Despite the inability
of insulin to stimulate glycogen synthesis in hearts from the
mPDK1/ or double GSK3a/GSK3b knockin mice, these ani-
mals possessed normal levels of cardiac glycogen, demonstrating
that total glycogen levels are regulated independently of insulins
ability to stimulate GS in the heart and that mechanisms such as
allosteric activation of GS by glucose-6-phosphate and/or activa-
tion of GS by muscle contraction, could operate to maintain nor-
mal glycogen levels in these mice. We also demonstrate that in
cardiomyocytes derived from the mPDK1/ hearts, although
the levels of glucose transporter type 4 (GLUT4) are increased
2-fold, insulin failed to stimulate glucose uptake, providing ge-
netic evidence that PDK1 plays a crucial role in enabling insulin
to promote glucose uptake in cardiac muscle.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The phosphoinositide 3-kinase (PI 3-kinase), 3-phosphoino-
sitide dependent protein kinase-1 (PDK1) and protein kinase B
(PKB also known as Akt) signalling cascade is believed to play
a key role in mediating the ability of insulin to simulate glucose
uptake and glycogen synthesis in skeletal muscle [1]. Insulin
stimulates glycogen synthase (GS), the rate-limiting enzymeAbbreviations: BSA, bovine serum albumin; G6P, glucose-6-phos-
phate; GLUT4, glucose transporter type 4; GSK3, glycogen synthase
kinase-3; PDK1, 3-phosphoinositide dependent protein kinase-1; PKB,
protein kinase B; PI 3-kinase, phosphatidylinositol 3-kinase
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doi:10.1016/j.febslet.2005.05.040in glycogen synthesis, by promoting its dephosphorylation at
a cluster of C-terminal residues (Ser641, Ser645, Ser649 and
Ser653). These residues are phosphorylated by glycogen syn-
thase kinase-3a (GSK3a) and GSK3b [2]. Insulin is thought
to induce dephosphorylation of GS by inhibiting GSK3a
and GSK3b following the phosphorylation of these enzymes
at an N-terminal Serine residue (Ser21 in GSK3a and Ser9
in GSK3b) by PKB [3]. Consistent with this model, inhibitors
of GSK3 stimulate GS activity in skeletal muscle [4].
Recently, we generated homozygous knockin mice in which
the PKB phosphorylation site on GSK3a (Ser21) and GSK3b
(Ser9) was changed to Ala to prevent inactivation of this en-
zyme by insulin [5]. We found that in skeletal muscle of the sin-
gle GSK3a21A/21A knockin mice, insulin induced normal
dephosphorylation and activation of GS. However, in single
GSK3b9A/9A or double GSK3a/b21A/21A/9A/9A knockin mice,
insulin failed to induce dephosphorylation and activation of
GS. These results indicate that insulin stimulates GS in skeletal
muscle by speciﬁcally inactivating GSK3b. We also found that
the protein levels of GSK3b in mouse skeletal muscle were 4-
fold higher than GSK3a, which may account for the dominant
role of GSK3b in the insulin-mediated regulation of GS [5].
Insulin stimulates glucose uptake in skeletal muscle as well
as the heart, by inducing the translocation of the glucose trans-
porter type 4 (GLUT4) glucose transporters, from intracellular
vesicles, to the plasma membrane. PI 3-kinase is believed to
regulate this process by stimulating the PKBb isoform, since
the ability of insulin to stimulate glucose uptake is impaired
in mice lacking PKBb [6], or in cells in which PKBb has been
depleted through RNAi-based approaches [7].
A common complication of type 2 diabetes is cardiovascular
disease, making it important to investigate the signalling net-
works that control insulin-regulated processes in the heart.
The purpose of this study was to deﬁne the role that the
PDK1–PKB–GSK3 pathway plays in regulating GS activity
and glucose transport speciﬁcally in the heart, utilizing previ-
ously described mice lacking PDK1 and hence the activity of
all PKB isoforms [8], as well as GSK3 knockin mice in which
GSK3 isoforms cannot be inactivated by insulin [5].2. Materials and methods
2.1. Materials
Protein G–Sepharose, 14C-UDP glucose, 2-deoxy-D-[1-3H]-glucose,
D-[14C]-mannitol, 32Pc-ATP were purchased from Amersham Pharma-
cia Biotech, protease-inhibitor cocktail tablets and fatty acid-free bo-
vine serum albumin (BSA) were from Roche, Tween-20, glycogen
Type III from rabbit liver and non-radioactive glucose-6-phosphateblished by Elsevier B.V. All rights reserved.
A. Mora et al. / FEBS Letters 579 (2005) 3632–3638 3633(G6P) were from Sigma, human insulin from Novo-Nordisk obtained
from Ninewells Pharmacy, Dundee, collagenase type II was from Wor-
thington Biochemical Corporation. All peptides were synthesized by
Dr. Graham Bloomberg at the University of Bristol (UK).
2.2. Antibodies
The following antibodies were raised in sheep and aﬃnity puriﬁed
on the appropriate antigen: total PDK1 (residues 540–559 of mouse
PDK1, RKIQEVWRQQYQSNPDAAVQ), total PKB (isolated PH
domain of PKBa), total GSK3a (residues 314–327 of mouse GSK3a,
LLGQPIFPGDSGVD used for immunoprecipitation), total GSK3b
(full length human protein used for immunoprecipitation) total GS
antibody was a mouse monoclonal antibody and was purchased from
Chemicon (#MAB3106). The phospho-Ser641 of GS (Ser641-P, resi-
dues 635–650 of mouse GS, RYPRPVpSVPPSPSLSR), phospho-
Ser645 of GS (Ser645-P, residues 635–650 of mouse GS,
RYPRPVSVPPpSPSLSR), phospho-Thr308 PKB (Thr308-P, residues
301–313 of human PKBa, KDGATMKpTFCGTP) and phospho-
Ser473 PKB (Ser473-P, residues 467–477 of human PKBa, KHFPQF-
pSYSAS). The total PKBa antibody used to immunoprecipitate PKBa
was a mouse monoclonal antibody raised against residues 1–149 of hu-
man PKB and was purchased from Upstate Inc. (#05–591). The fol-
lowing antibodies were purchased from the indicated companies:
phospho-Ser21/Ser9 GSK3a/GSK3b (Ser21-P/Ser9-P Cell Signaling
Technology#9336), the Pan-GSK3 isoform antibody (Biosource
#44–610), and the GLUT4 antibody (abcam #ab654).
2.3. Glycogen determination
The amount of glycogen was measured as described previously [9].
Triplicate samples per heart were analysed and data presented as lmol
of glucosyl units per mg of heart tissue.
2.4. Genotype analysis and breeding of mice
All animal studies and breeding performed in this study were ap-
proved by the University of Dundee ethical committee and performed
under a UK Home Oﬃce project license. PDK1ﬂDneo/ﬂDneo mice were
generated and genotyped as previously described [10] and backcrossed
for 6 generations to the C57BL/6j strain. These were crossed to trans-
genic mice expressing Cre recombinase under muscle creatine kinase
promoter (MckCre) [11], which had been backcrossed for 8 genera-
tions to the C57BL/6j strain. The GSK3 knockin mice were bred and
genotyped as described previously [5].2.5. Buﬀers
Lysis Buﬀer: 50 mM Tris–HCl, pH 7.5, 1 mM EDTA, 1 mM EGTA,
1% (w/v) Triton X-100, 0.1% (v/v) b-mercaptoethanol, 1 mM sodium
orthovanadate, 50 mM sodium ﬂuoride, 5 mM sodium pyrophosphate,
1 lMmicrocystin-LR and one tablet of complete proteinase inhibitor
per 50 ml of buﬀer.
2.6. Preparation of tissue extracts, immunoblotting and protein kinase
assays
Following an overnight fast, a bolus of insulin (150 mU/g) or saline
solution was injected intraperitoneally to anaesthetized mice. At the
indicated times, the heart was rapidly extracted, freeze clamped in li-
quid nitrogen, stored at 80 C and homogenized to a powder in li-
quid nitrogen. A 10-fold mass excess of ice-cold Lysis Buﬀer, was
added to the powdered tissue, brieﬂy vortexed and then centrifuged
at 4 C for 10 min at 13000 · g to remove insoluble material. The
supernatant was snap frozen in aliquots in liquid nitrogen and stored
at 80 C. The activation state of PKB, was assessed following its
immunoprecipitation from cell extracts by assaying its activity using
the Crosstide peptide (GRPRTSSFAEG) as described previously
[12]. The activity of GSK3a and GSK3b was measured following the
immunoprecipitation of each isoform with speciﬁc antibodies and as-
sayed using the Phospho-GS2 (YRRAAVPPSPSLSRHSSPHQpSE-
DEEE, 20 lM) substrate as described before [5].2.7. Immunoblotting
Unless indicated otherwise, 20 lg of protein lysate in SDS Sample
Buﬀer was subjected to SDS/polyacrylamide gel electrophoresis and
transferred to nitrocellulose. For all blots, the nitrocellulose mem-branes were incubated at 4 C for 16 h using the indicated antibodies
(1 lg/ml for the sheep antibodies or 1000-fold dilution for commercial
antibodies) in the presence of 10 lg/ml of the de-phosphopeptide anti-
gen used to raise the antibody for sheep phospho-speciﬁc antibodies.
The blots were incubated in 50 mM Tris/HCl, pH 7.5, 0.15 M NaCl,
0.2% (by vol) Tween containing 5% (by mass) skimmed milk. Detec-
tion of total or phosphorylated protein was performed using horse rad-
ish peroxidase conjugated secondary antibodies and the enhanced
chemiluminescence reagent. Quantitative immunoblot analysis was
carried out employing a LI-COR Odyssey infrared detection system
following the manufactures guidelines (see http://www.licor.com/).
2.8. Cardiomyocyte isolation and glucose transport activity
Cardiomyocytes from mice were prepared by collagenase digestion
as described previously [13] except that 20 mM inosine was included
in the ﬁnal cell suspension [14]. Glucose transport in isolated cardio-
myocytes was measured as described previously [14].
2.9. Glycogen synthase assay
Following an overnight fast, a bolus of insulin (150 mU/g) or saline
solution was injected intraperitoneally to anaesthetized mice. At the
indicated times, the heart was rapidly extracted and freeze clamped
in liquid nitrogen, stored at 80 C and homogenized to a powder in
liquid nitrogen and theGSactivitywasmeasured as describedpreviously
[15]. The GS activity ratio is deﬁned as activity measured in the absence
of G6P divided by activity measured in the presence of G6P.3. Results
3.1. Analysis of GSK3, GS and glycogen content in mPDK1/
hearts
We have previously described the generation and phenotype
of muscle-speciﬁc PDK1 knockout mice (termed mPDK1/)
that completely lack PDK1 expression in cardiac muscle [8].
As mPDK1/ mice become ill, develop heart failure and die
between 6 and 11 weeks of age [8], we ensured that we utilized
mice of between 4 and 5 weeks of age that displayed no signs of
ill health. In mPDK1/ mice, PDK1 expression is completely
ablated in heart muscle [8] (inset in Fig. 1B), but low levels of
PDK1 is still expressed in skeletal muscle resulting in PDK1
dependent pathways being triggered by insulin in the skeletal
muscle of these mice (A.M., unpublished data).
To determine whether lack of cardiac PDK1 expression im-
paired activation of enzymes of the glycogen synthesis path-
way, mPDK1/ and control mPDK1+/+ mice were injected
with insulin for varying times (0, 10, 20 and 40 min) and heart
extracts generated. For each time point and genotype, 3 mice
were employed. PKBa activity was measured using a quantita-
tive immunoprecipitation kinase assay. Consistent with our
previous ﬁndings [8], insulin-stimulated PKB activity over
20-fold in control mPDK1+/+ mice within 10 min, but no sig-
niﬁcant activation was observed up to 40 min in mPDK1/
hearts (Fig. 1B). We next studied the phosphorylation of the
inhibitory PKB phosphorylation sites on GSK3a (Ser21) and
GSK3b (Ser9) employing phospho-speciﬁc antibodies. As ex-
pected, insulin-induced phosphorylation of both GSK3 iso-
forms within 10 min in the control mPDK1+/+ hearts, but no
detectable increase above the basal levels of phosphorylation
of GSK3 isoforms was seen at any time point in the
mPDK1/ hearts injected with insulin. Employing phospho-
speciﬁc antibodies recognizing the Ser641 and Ser645 GSK3
phosphorylation sites on GS, we demonstrated that in the con-
trol mPDK1+/+ hearts, insulin induced a marked dephospho-
rylation of these residues within 10 min. In the mPDK1/
Fig. 1. Eﬀect of insulin on PKB, GSK3 and GS in mPDK1/ heart. (A) Diagram summarizing the mechanism by which insulin is thought to
regulate GS. (B–D) The mPDK1+/+ and mPDK1/ mice were fasted overnight, anaesthetized and then injected intraperitoneally with insulin
(150 mU/g) or saline solution (for the 0 min time point). At the indicated time (10 min for saline control), the heart was rapidly extracted and snap
frozen in liquid nitrogen. (B) PKBa activity was measured following its immunoprecipitation. The results shown at each time point represent the
means ± S.E.M. for three mice each assayed in triplicate. In the inset, 40 lg of heart extract from the indicated mice were immunoblotted with an
anti-PDK1 antibody. (C) Heart extracts from the indicated mice were immunoblotted with the indicated antibodies. For each time point heart
samples from 2 separate mice are shown. (D) GS activity was measured in the absence and presence of G6P. The data are presented as the
means ± S.E.M. for heart isolated from 3 mice each assayed ±G6P in triplicate. (E) mPDK1+/+ and mPDK1/ mice were fasted overnight for 16 h
(Fasted) or fed ad libitum (Fed). The mice were sacriﬁced and the heart was rapidly extracted and glycogen content determined. The glycogen content
is expressed as lmol of glucosyl units per mg of muscle. The data are presented as the means ± S.E.M. for cardiac muscle isolated from 3 mice in each
group each assayed in triplicate.
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of phosphorylation of Ser641 and Ser645 sites was similar to
that observed in the mPDK1+/+ mice, however, insulin failed
to induce any signiﬁcant dephosphorylation of these residues
in the mPDK1/ hearts (Fig. 1C). Immunoblot analysis indi-
cated that the levels of GS were identical in mPDK1/ and
mPDK1+/+ hearts, although GSK3 isoforms were expressed
at slightly higher levels in mPDK1/ hearts used for these
studies (Fig. 1C). We are not of the opinion that this diﬀerence
is signiﬁcant, as in other mPDK1/ hearts we have notobserved changes in the expression of GSK3 isoforms (A.M.,
data not shown [8]).
We next measured GS activity in heart extracts in the pres-
ence or absence of G6P, an allosteric activator of GS. In the
control mPDK1+/+ hearts, insulin induced a 2-fold increase in
the GS activity ratio within 10 min, which was sustained for
up to 40 min (Fig. 1D). In the mPDK1/ hearts, the basal /+
G6P GS activity ratio was identical to that observed in the
wild type mPDK1+/+ mice. Strikingly, however, insulin failed
to stimulate GS activity in mPDK1/ heart (Fig. 1D). We also
A. Mora et al. / FEBS Letters 579 (2005) 3632–3638 3635measured total glycogen content in mPDK1/ and mPDK1+/+
hearts, and found that the levels were not signiﬁcantly diﬀerent
in both genotypes, fasted or fed ad libitum (Fig. 1E).3.2. Analysis of GS and glycogen content in hearts of GSK3
knockin mice
Single homozygous GSK3a21A/21A and GSK3b9A/9A as well
as double GSK3a/b21A/21A/9A/9A knockin mice were bred as de-
scribed previously [5]. Mice were fasted overnight and injected
with insulin, and PKB activity was assessed by analysis of its
phosphorylation at its activating Thr308 and Ser473 residues.
In the heart of the single GSK3a21A/21A, GSK3b9A/9A and dou-
ble GSK3a/b21A/21A/9A/9A knockin mice, insulin induced robust
phosphorylation of PKB at Thr308 and Ser473 residues, simi-
lar to that seen in wild type control mice (Fig. 2A). We next
assayed the insulin-induced phosphorylation of GSK3a at
Ser21 and GSK3b at Ser9 employing phospho-speciﬁc anti-
bodies. Insulin-stimulated phosphorylation of both GSK3 iso-
forms in wild type control mice (Fig. 2A). In the GSK3a21A/21A
knockin mice, no phosphorylation of GSK3a at Ser21 was
seen, while phosphorylation of GSK3b at Ser9 was normal.
In the GSK3b9A/9A knockin mice, no phosphorylation of
GSK3b at Ser9 was observed, while phosphorylation of
GSK3a at Ser21 was unaﬀected. As expected, in the doubleFig. 2. PKB and GSK3 activity in GSK3 knockin mice. The indicated wild ty
and injected intraperitoneally with insulin (150 mU/g) or saline solution (fo
(10 min for saline control), the hearts were rapidly extracted and snap frozen
indicated antibodies. For each time point cardiac muscle samples from 3 sepa
presence of G6P. The data are presented as the means ± S.E.M. for heart isol
in A, B and C, data were obtained with the three sets of knockin mice were ea
the sets of wild type controls did not diﬀer signiﬁcantly from each other, only
are shown. (D) The wild type and double knockin GSK3a/b21A/21A/9A/9A wer
were sacriﬁced and the heart was rapidly extracted and glycogen content deter
mg of heart. The data are presented as the means ± S.E.M. for cardiac musknockin GSK3a/b21A/21A/9A/9A mice, phosphorylation of nei-
ther isoform of GSK3 was detected. The levels of GSK3a
and GSK3b isoforms in the hearts of knockin mice were sim-
ilar to those found in the wild type mice (Fig. 2A).
We next studied the level and activity of GS in cardiac mus-
cle extracts. GS protein levels were normal in the muscles of
knockin mice (Fig. 2B). In wild type mice, similar to that ob-
served with the mPDK1+/+ mice (Fig. 1D), insulin activated
GS 2-fold, as judged by an increase in the /+ G6P GS activ-
ity ratio of 0.42–0.76, which was sustained for up to 40 min
(Fig. 2C). This activation was accompanied by dephosphoryla-
tion of Ser641 and Ser645 (Fig. 2A). In the single GSK3a21A/21A
knockin mice, the basal level of GS activity was normal,
and insulin induced a 2-fold activation after 10 min that
was sustained for 20 min, but reduced after 40 min (Fig. 2C).
Activation of GS in the single GSK3a21A/21A knockin mice
was accompanied by the dephosphorylation of Ser641 and
Ser645 (Fig. 2A). In the single GSK3b9A/9A knockin mice,
the basal /+ G6P GS activity ratio was 0.33 lower than the
0.42 observed in wild type or GSK3a21A/21A knockin mice.
In the single GSK3b9A/9A knockin mice, insulin still stimulated
GS, but to an activity ratio of only 0.6, less than that observed
in the wild type or single GSK3a21A/21A animals. Importantly,
however, in the double GSK3a/b21A/21A/9A/9A knockin mice,
the basal activity of GS (0.34) was comparable to thatpe (WT) and GSK3 knockin mice were fasted overnight, anaesthetized
r the 0 min time point), to anaesthetized mice. At the indicated time
in liquid nitrogen. (A, B) Heart extracts were immunoblotted with the
rate mice are shown. (C) GS activity was measured in the absence and
ated from 3 mice each assayed ±G6P in triplicate. For the experiments
ch compared to wild type littermate control mice. Since these data from
the results obtained for the wild type GSK3a21A/21A littermate controls
e fasted overnight for 16 h (Fasted) or fed ad libitum (Fed). The mice
mined. The glycogen content is expressed as lmol of glucosyl units per
cle isolated from 3 mice in each group each assayed in triplicate.
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lin failed to induce a signiﬁcant activation or dephosphoryla-
tion of the Ser641 and Ser645 residues of GS (Fig. 2A). We
also quantiﬁed glycogen levels in double GSK3a/b21A/21A/9A/9A
knockin hearts, and found that glycogen content was similar
to that found in wild type hearts from fasted or fed mice
(Fig. 2D).
3.3. Relative expression and activity of GSK3a and GSK3b in
cardiac muscle
In the skeletal muscle of single GSK3b9A/9A knockin mice
[5], in contrast to what is observed in the heart (Fig. 2), insulin
failed to stimulate GS. To verify whether the ability of insulin
to stimulate GS in cardiac muscle of single GSK3b9A/9A knoc-
kin mice compared to skeletal muscle, could be caused by dif-
ferences in the level of expression of GSK3a and GSK3b
isoforms in muscle and heart, we compared the relative levels
of GSK3a and GSK3b in these tissues. Using an antibody rec-
ognizing GSK3a and GSK3b isoforms, we found that both
GSK3 isoforms were expressed at 2-fold higher levels in
heart compared to skeletal muscle (Fig. 3A). The ratios of
GSK3a and GSK3b were not markedly diﬀerent between heart
and skeletal muscle (Fig. 3A). The speciﬁc activity of GSK3a
and GSK3b as judged by quantitative immunoprecipitation ki-
nase assay, was 2–3-fold higher in heart compared to skeletal
muscle (Fig. 3B).
3.4. Analysis of GLUT4 levels and glucose uptake in mPDK1/
cardiomyocytes
Insulin stimulates glucose uptake in muscle by inducing the
recruitment of the GLUT4 glucose transporter to the plasma
membrane. We ﬁrst compared the levels of expression of
GLUT4 in mPDK1/ and mPDK1+/+ hearts in total tissueFig. 3. Relative levels of GSK3a and GSK3b in heart and skeletal
muscle. (A) The indicated amounts of mouse skeletal muscle and heart
derived from 3 wild type mice were subjected to quantitative immu-
noblot analysis with the Pan-GSK3 isoform antibody. (B) GSK3a and
GSK3b were immunoprecipitated from the same amount of skeletal
and heart muscle employing isoform-speciﬁc antibodies and their
activity was measured. The data are presented as the means ± S.E.M.
for muscle isolated from 3 mice each assayed triplicate.extracts using quantitative immunoblot LI-COR analysis.
The GLUT4 levels were found to be 2-fold higher in total
extracts of those derived from mPDK1/ hearts compared
to wild type mPDK1+/+ hearts (Fig. 4A). We also generated
plasma membrane fractions from hearts, and observed that
the GLUT4 levels were also 2-fold higher in membranes de-
rived from mPDK1/ hearts, compared to those from control
hearts (A.M. data not shown). We next measured glucose up-
take in isolated cardiomyocytes that were incubated for 30 min
in the presence or absence of insulin, followed by 10 min inFig. 4. GLUT4 levels and insulin stimulated glucose uptake in
mPDK1/ cardiomyocytes. (A) The indicated total extract derived
from 3 separate mPDK1/ and mPDK1+/+ hearts was subjected to
immunoblot analysis with anti-GLUT4 antibody. Quantiﬁcation of
the immunoblots was performed using the LI-COR system. The upper
panel displays the primary immunoblot analysis, whilst in the lower
panel the quantiﬁed GLUT4 amount (means ± S.E.M.) for heart
isolated from 3 mice is displayed. (B) Cardiomyocytes were isolated
from mPDK1/ and mPDK1+/+ hearts and glucose transport
activities were determined without or with 30 nM insulin, as described
in the experimental procedures. The data are presented as the
means ± S.E.M. for cardiomyocytes isolated from 3 mice for each
genotype.
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myocytes, insulin stimulated glucose uptake 2-fold. In
mPDK1/ cardiomyocytes, the basal level of glucose trans-
port was similar to control cells, but insulin failed to induce
a signiﬁcant increase in glucose uptake (Fig. 4B).4. Discussion
Our ﬁndings provide strong evidence that inactivation of
GSK3 is the major regulatory step in the mechanism by which
insulin stimulates GS in cardiac muscle. It has also been sug-
gested in skeletal muscle that insulin could stimulate GS by
increasing the activity of a glycogen-associated form of protein
phosphatase-1 protein by an unknown mechanism [16,17]. If
this was the case in cardiac muscle, our ﬁndings suggest that
the activity of this phosphatase would also need to be con-
trolled by GSK3 isoforms. As Ser641 and Ser645 are not
dephosphorylated in response to insulin in the double
GSK3a/b21A/21A/9A/9A knockin mice, our ﬁndings indicate that
GSK3 isoforms are the major enzymes phosphorylating Ser641
and Ser645 and regulating GS activity in response to insulin in
cardiac muscle.
An interesting observation was that GS was not activated by
insulin in skeletal muscle of single GSK3b9A/9A knockin mice
[5], but was still partially activated in the cardiac muscle of
these animals (Fig. 2C). Thus, the prominence of GSK3b in
regulating GS activity is diﬀerent in skeletal and cardiac mus-
cle. These observations might be accounted for the 2–3-fold
greater abundance of GSK3a in heart (Fig. 3), which might en-
hance the contribution that GSK3a plays in regulating GS
activity.
Heart from mPDK1/ and GSK3a/b21A/21A/9A/9A mice pos-
sessed normal levels of glycogen despite insulin being unable to
stimulate activation of GS (Figs. 1E and 2D). We previously
reported that the single and double GSK3 knockin mice dis-
played normal blood glucose and insulin levels and are not glu-
cose intolerant [5]. Moreover, these animals also have normal
levels of glycogen in their skeletal muscle [5], indicating that
mechanisms independent from the PDK1–PKB–GSK3 path-
way play an important role in maintaining normal glycogen
levels in both skeletal and cardiac muscle. GS activity is not
only activated by dephosphorylation, but also by G6P [18].
At saturating concentrations of G6P and UDP-glucose, the
activities of the dephosphorylated and phosphorylated forms
of GS are identical in vitro. Thus, the similar levels of glycogen
observed in the wild type and GSK3 knockin mice might be ex-
plained, if activation of GS by G6P can compensate for the
failure of insulin to induce the dephosphorylation of GS, in
the skeletal muscle of knockin mice expressing GSK3 mutants
that cannot be inactivated by insulin. Muscle contraction also
stimulates glucose uptake independently from PI 3-kinase,
through a pathway involving the AMP-activated protein ki-
nase [19,20]. Moreover, muscle contraction also potently stim-
ulates GS through a poorly understood mechanism, which
might result from depletion of cellular glycogen and/or activa-
tion of a protein phosphatase [21]. It is therefore possible that
the continuous contraction of cardiac muscle in the beating
heart ensures that suﬃcient glucose is transported into cardio-
myocytes, and that glycogen is synthesized without the need of
insulin to stimulate these processes through the PDK1–PKB–GSK3 pathway. We have previously demonstrated that the
muscle contraction stimulates GS activity normally in the skel-
etal muscle of double GSK3 knockin mice [5]. We are unable
to rule out the possibility that degradation of glycogen is al-
tered in the mPDK1/ or GSK3 knockin mice, that could ac-
count for normal levels of glycogen. However, to our
knowledge the PDK1–PKB–GSK3 signalling pathway has
not been reported to control glycogen breakdown.
Long-chain fatty acids rather than glycogen are considered
to be the major substrates for ATP production in adult heart
[22,23]. If glycogen is not an important fuel source in the adult
mouse heart, this might also account for our ﬁnding that the
PDK1–PKB–GSK3 pathway does not play a major role in
maintaining normal glycogen levels in the heart. However, glu-
cose does become a signiﬁcant source of energy when blood
glucose and insulin concentrations are high, such as after a
meal [22,23]. Moreover, when the workload of the heart is in-
creased, such as after stimulation by epinephrine or increased
exercise, glycogen provides a readily accessible source of addi-
tional energy [24,25]. In future work, it would be interesting to
monitor glycogen levels under these conditions in the GSK3
knockin hearts. During embryo development glycogen is
thought to play a major role in fuelling contraction, and con-
sistent with this, mice lacking the muscle isoform of GS and
hence glycogen, display abnormal cardiac development [26].
We have not examined glycogen levels of developing embryos
in the GSK3 knockin mice, but these animals are born at
about the expected Mendelian frequency and displayed no
marked cardiac phenotypes [5].
The role of PDK1 in regulating insulin-stimulated glucose
transport has previously been analysed in cultured diﬀerenti-
ated 3T3L1 adipocytes [27,28] and immortalized brown adipo-
cytes [29], but to our knowledge not in muscle. Two groups
have overexpressed PDK1 in 3T3L1 adipocytes and reported
that this did not stimulate glucose transport, leading them to
conclude that PDK1 was not required for this process
[27,28]. These ﬁndings were surprizing given the strong evi-
dence outlined in the introduction that PKB activation medi-
ates insulin stimulated glucose uptake. As PKB can only be
activated by PDK1 in the presence of the phosphatidylinosi-
tol-3,4,5-trisphosphate second messenger, generated through
activation of PI 3-kinase by insulin (reviewed in [30]), it is pos-
sible that overexpression of PDK1 in adipose-like cells is not
suﬃcient to stimulate PKB in the absence of PI 3-kinase acti-
vation. Recently, Kasuga and co-workers [29] demonstrated
that insulin failed to stimulate glucose uptake in PDK1 knock-
out immortalized brown adipocytes, showing that PDK1 does
indeed play an important role in stimulating glucose uptake in
fat cells. Our ﬁndings in isolated mPDK1/ cardiomyocytes
conﬁrm the vital role that PDK1 plays in regulating glucose
uptake in a muscle cell type for the ﬁrst time, consistent with
the notion that PKB plays an important role in regulating
insulin-stimulated glucose transport.
We also noted that the levels of the GLUT4 glucose trans-
porter were elevated 2-fold in cardiac muscle lacking
PDK1. Interestingly, mice lacking expression of the insulin
receptor in the heart was also found to possess 2-fold higher
levels of GLUT4 protein expression in the heart [31]. These
ﬁndings suggest that GLUT4 levels are negatively controlled
by insulin working through a PDK1 regulated pathway, and
might represent a mechanism by which a deﬁciency of the insu-
lin-signalling network could result in a compensatory increase
3638 A. Mora et al. / FEBS Letters 579 (2005) 3632–3638in GLUT4 levels, to enhance glucose transport into cardio-
myocytes. It should be noted, however, in cardiomyocytes de-
rived from hearts lacking either the insulin receptor [31] or
PDK1 (Fig. 4), the basal level of glucose uptake in the absence
of insulin, is not enhanced, despite the increased levels of
GLUT4. However, it is possible that in the contracting intact
heart, higher levels of GLUT4 could help to compensate for
the lack of insulin stimulated glucose uptake, which could also
aide in maintaining normal glycogen levels.
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